Second Update for Anaesthetists on Clinical Features of COVID-19 Patients and Relevant Management

Robert P Weenink; Benedikt Preckel; Abraham H Hulst; Jeroen Hermanides; Menno D de Jong; Wolfgang S Schlack; Markus F Stevens; Nicolaas H Sperna Weiland; Markus W Hollmann

doi:10.3390/jcm9082542

Second Update for Anaesthetists on Clinical Features of COVID-19 Patients and Relevant Management

J Clin Med. 2020 Aug 6;9(8):2542. doi: 10.3390/jcm9082542.

Authors

Affiliations

¹ Department of Anesthesiology, Amsterdam University Medical Centers, Location AMC, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
² Laboratory of Experimental Intensive Care and Anesthesiology (LEICA), Amsterdam University Medical Centers, Location AMC, 1105 AZ Amsterdam, The Netherlands.
³ Department of Medical Microbiology & Infection Prevention, Amsterdam University Medical Centers, Location AMC, 1105 AZ Amsterdam, The Netherlands.

Abstract

The COVID-19 pandemic poses great challenges for healthcare workers around the world, including perioperative specialists. Previously, we provided a first overview of available literature on SARS-CoV-2 and COVID-19, relevant for anaesthetists and intensivists. In the current review, we provide an update of this topic, after a literature search current through May 2020. We discuss the evidence on perioperative risk for COVID-19 patients presenting for surgery, the risk of transmission of SARS-CoV-2 in the operating room, and the current literature on laboratory diagnostics. Furthermore, cardiovascular and nervous system involvement in COVID-19 are discussed, as well as considerations in diabetic patients. Lastly, the latest evidence on pharmacological treatment is summarised.

Keywords: COVID-19; SARS-CoV-2; angiotensin converting enzyme 2; antiviral agents; patient-to-professional infectious disease transmission; perioperative care.

Publication types

Review